Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm&s;s mission is to focus on providing healthcare solutions for patients worldwide through the creation of and investment in bioventure companies. Catalys Pacific is led by a global team versed in working closely with its partners in academia, biotech, venture capital and the pharmaceutical industry in Japan and worldwide. The firm maintains offices in Tokyo and Kanagawa (Shonan Health Innovation Park), Japan and in Seattle, Washington.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2019 | Phathom Pharmaceuticals | Private Equity Round | 90M |
4/2021 | Mineralys Therapeutics | Series A | 0 |
10/2021 | Aculys Pharma | Series A | 0 |
6/2022 | Mineralys Therapeutics | Series B | 0 |
1/2023 | Pathalys Pharma | Series A | 0 |
6/2021 | Pathalys Pharma | Seed Round | 0 |
9/2021 | HilleVax | Equity | 135M |
3/2022 | Aculys Pharma | Series B | 0 |
7/2020 | Exalys Therapeutics | Series A | 15M |
4/2021 | Mineralys Therapeutics | Seed Round | 0 |
6/2022 | Mineralys Therapeutics | Series B | 0 |
3/2022 | Aculys Pharma | Series B | 0 |
10/2021 | Aculys Pharma | Series A | 0 |
9/2021 | HilleVax | Venture Round | 0 |
6/2021 | Pathalys Pharma | Seed Round | 0 |
4/2021 | Mineralys Therapeutics | Seed Round | 0 |
4/2021 | Mineralys Therapeutics | Series A | 0 |
7/2020 | Exalys Therapeutics | Series A | 0 |
5/2019 | Phathom Pharmaceuticals | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|